# Multiple-Ascending Dose in Japanese Patients Bridging Study

> **NCT05065359** · PHASE1 · COMPLETED · sponsor: **Altavant Sciences GmbH** · enrollment: 47 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rodatristat Ethyl 300 mg BID
- **DRUG:** Rodatristat Ethyl 600 mg BID
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05065359
- **Lead sponsor:** Altavant Sciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065359, "Multiple-Ascending Dose in Japanese Patients Bridging Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05065359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*